Determining the right amount of behavioral support for improving HIV care
DOSE DETERMINATION TRIAL FOR IMPLEMENTING EVIDENCE-BASEDBEHAVIORAL INTERVENTIONS
This study is looking at how different amounts of support and counseling can help people with HIV stick to their treatment and stay healthy, and it’s for anyone who wants to improve their care and treatment experience.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Storrs NIH-funded |
| Lab location | 1 site (Storrs-Mansfield, United States) |
| Project ID | NIH-10745908 on NIH RePORTER |
What this research studies
This research investigates how different levels of behavioral counseling can enhance engagement in HIV care and adherence to antiretroviral therapy (ART). It aims to identify the minimum effective dose of these interventions needed for patients to achieve viral suppression. Participants will be randomized to receive varying intensities of counseling, allowing researchers to assess which groups of patients may need more or less support. The study also evaluates the costs associated with these interventions to inform healthcare policy and implementation strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are currently receiving ART but have not achieved viral suppression.
Not a fit: Patients who are already virally suppressed or not receiving ART may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and tailored behavioral interventions for individuals living with HIV, improving their health outcomes.
How similar studies have performed: While behavioral interventions for HIV care have been studied, this specific dose-determination approach is novel and has not been previously tested.
Where this research is happening
Storrs-Mansfield, United States
- University of Connecticut Storrs — Storrs-Mansfield, United States (Active)
Researchers
- Principal investigator: Kalichman, Seth C — University of Connecticut Storrs
- Study coordinator: Kalichman, Seth C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.